https://www.selleckchem.com/pr....oducts/mmp-9-in-1.ht
04). The OS of patients with a high AGR (≥1.12) was longer than that of patients with a low AGR ( less then 1.12). PFS in the high AGR group were better than those in the low AGR group (16.90 vs. 32.07months, p = 0.008). The univariate and multivariate models proved that the AGR was an independent prognostic factor in metastatic NSCLC patients in terms of both OS (p = 0.009, hazard ratio [HR] = 0.55, 95% confidence interval [95% CI] = 0.35-0.86) and PFS (p = 0.004, HR = 0.55, 95% CI = 0.37-0.83). Conclusion The AGR, which is measured